Don’t let the cost of inhaled tobramycin disrupt cystic fibrosis care. Between the ~90%-off generic solution, the $0 Podhaler savings card, the Viatris Patient Assistance Program, and CF Foundation Compass, an affordable route exists for nearly every situation. We find yours and manage it for a flat $69.95 per month.
The TOBI Patient Assistance Program is run by Viatris (1-888-417-5782, Mon–Fri 8 AM–5 PM CT) and provides free medication for 12-month enrollments (up to 11 refills) to patients without prescription drug coverage who meet the program’s financial screening, with the PODCARE+ support hub (1-877-999-8624) handling Podhaler onboarding. But inhaled tobramycin is really a two-product, two-billing-system drug, and the affordability answer depends on which you use: the nebulizer solution is deeply genericized (~$861 per cycle, ~90% off brand) and — for Medicare — bills under Part B as a nebulizer/DME medication at a Part B-enrolled pharmacy; the Podhaler is brand-only, bills under Part D (where the $2,100 cap applies), and carries a $0-per-cycle savings card for the commercially insured, capped at $14,000 a year. Layered over everything is cystic fibrosis’s own safety net: CF Foundation Compass provides free, expert insurance and financial navigation, and CF care centers have social workers who know these programs cold. For a flat $69.95 per month, our Patient Advocates coordinate all of it — form selection economics, billing routing, card and PAP filings, and the on/off cycle refill rhythm that inhaled antibiotics demand.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$7,200/cycle | Save substantially |
| CVS Pharmacy (brand) | ~$7,500/cycle | Save substantially |
| Walmart (brand) | ~$5,800/cycle | Save substantially |
| Costco (brand) | ~$5,600/cycle | Save substantially |
Generic tobramycin inh | ~$2,000/cycle | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Viatris PAP, the savings card, and CF Compass are all free to use directly. Our $69.95/month service covers full advocacy — the form-selection economics, the Part B/Part D routing, the filings, and the cycle-timed refills, coordinated with your CF care center and alongside the rest of a CF regimen that’s never just one drug.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for TOBI:
Still $5,500–$7,500/cycle per month even with the best discount
The Viatris Patient Assistance Program reviews eligibility on insurance status and financial need. You will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for TOBI assistance:
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
TOBI is tobramycin — an aminoglycoside antibiotic — delivered straight into the lungs, where it attacks the Pseudomonas aeruginosa infections that drive lung-function decline in cystic fibrosis, at airway concentrations no IV or oral dose could safely match.
How TOBI Works:
In CF, thick mucus turns airways into a permanent harbor for Pseudomonas, and chronic infection means chronic inflammation and scarring. Inhaled tobramycin concentrates the antibiotic exactly where the bacteria live — suppressing bacterial density, improving lung function, and reducing hospitalizations — while keeping systemic exposure (and the kidney/hearing toxicity aminoglycosides are known for) far lower than IV dosing. The alternating 28-days-on / 28-days-off rhythm limits resistance pressure while maintaining suppression.
Form and Use:
Two forms, one drug: the nebulizer solution (300 mg twice daily, ~15–20 minutes per session plus equipment cleaning) and the TOBI Podhaler (four dry-powder capsules inhaled twice daily in a few minutes, no nebulizer, no refrigeration — a genuine life-burden reduction for students, workers, and travelers). Twice daily, every on-cycle day, then four weeks off, indefinitely. The cycle rhythm is the refill trap: an on-cycle that starts late because a fill lagged is suppression lost — so we time every fill to the calendar, not the pharmacy queue.
Generic Availability:
Split down the middle: the solution has been generic for years — multiple manufacturers, about $861 per cycle, roughly 90% below brand — while the Podhaler remains brand-only, with device patents running to 2028–2030. That asymmetry is the whole cost decision: identical antibiotic, radically different price and convenience. Which trade-off fits is a conversation between you, your CF team, and the math — we bring the math.
Warnings:
Inhaled tobramycin can cause bronchospasm (a bronchodilator beforehand helps many patients), voice changes, and tinnitus; aminoglycoside class risks — hearing loss, kidney effects, neuromuscular issues — are much lower than IV but not zero, and baseline/periodic hearing checks are prudent, especially with prior IV aminoglycoside exposure. Tell your team about kidney disease, hearing problems, or pregnancy. Report new ringing in the ears or dizziness promptly — early detection preserves hearing.
Brand solution runs about $8,455 per 28-day cycle and the Podhaler about $11,455 — but generic tobramycin solution runs roughly $861 per cycle, and eligible uninsured patients can receive medication free through the Viatris PAP. Our $69.95 monthly fee covers routing every cycle to the cheapest correct path.
Same antibiotic, same lungs — the difference is delivery and time: ~15–20 minutes of nebulization plus cleaning versus a few minutes with a pocket inhaler. Clinically both are guideline options; practically, adherence often improves with the Podhaler, and cost often favors the solution by thousands per cycle. That trade-off deserves real numbers, which we provide.
Yes, but the two forms route differently: the nebulized solution bills under Part B as a DME/nebulizer drug — your pharmacy must be a Part B-enrolled supplier, and 20% coinsurance applies (a supplement absorbs it) — while the Podhaler bills under Part D, where the $2,100 annual cap (2026) applies. Most Medicare billing surprises on this drug are routing errors, and they’re fixable.
No — it’s commercial-insurance only (up to $14,000 per calendar year). Medicare patients rely on the routing above, Extra Help if income-qualified, or the PAP if uninsured.
A free service of the Cystic Fibrosis Foundation (1-844-COMPASS) staffed by case managers who untangle insurance, coverage appeals, and financial assistance for anyone with CF — no income test, no charge. Every CF family should have Compass’s number saved; we work alongside them, not instead of them.
Currently closed to new patients for lack of funding — worth checking periodically because funds reopen, which we monitor. Until then, the card, the PAP, Compass, and generic economics are the working routes.
Denials are usually about documentation — income screening or coverage-status details (the PAP serves the fully uninsured). Applications can be corrected and resubmitted, and the generic solution bridges the gap while anything is appealed. We review the denial letter, fix what triggered it, and resubmit on your behalf.
A ~90%-off generic, a $0 card, a free-drug program, and a CF-specific navigation service — inhaled tobramycin has routes for every situation; the complexity is that each form bills differently and the cycles never stop. Managing that rhythm is our job. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.